News & Updates

Massive single-cell study suggests biological roots of COVID-19 risk factors

03/09/2021

Excerpt from the Article: It’s rare for current events to inform the work of scientists as acutely as during a pandemic. In February 2020, a team of scientists from the international initiative of the Human Cell Atlas, including scientists at the Broad Institute of MIT and Harvard, sifted through a dataset on healthy human cells…

Read More

CT Colonography Identifies Pre-Malignant Polyps with Machine-Based Learning Algorithm

03/09/2021

Excerpt from the Article: Implementing a radiomics-based machine learning algorithm allows CT colonography to differentiate between benign and pre-cancerous polyps with high sensitivity and specificity. Applying a machine-based learning algorithm to images captured with CT colonography makes it possible for radiologists to differentiate between benign and pre-malignant colorectal polyps. In industrialized countries across the globe,…

Read More

Ask Us Anything in Clinical Research – The Ins and Outs of Imaging Based Clinical Trials

03/08/2021

On February 25th, we hosted our virtual networking meeting focused on the complexities of imaging based clinical trials. Thank you to everyone who participated in this exciting discussion. For those of you who wanted to join but could not, you can watch the recording below, and also register for our upcoming meetings! Register for the…

Read More

4D-Fueled AI with DCE-MRI Improves Breast Lesion Characterization

03/08/2021

Excerpt from the Article: Radiologists can classify breast lesions more accurately if they use artificial intelligence algorithms fueled by 4D data captured with dynamic contrasted-enhanced MRI (DCE-MRI), new research has found. In a study published on Feb. 24 in Radiology: Artificial Intelligence, investigators from the University of Chicago outlined their method for fusing the 4D…

Read More

Machine Learning with Contrast-Enhanced CT Can Help Identify Pulmonary Hypertension

03/08/2021

Excerpt from the Article: Using automated machine learning to calculate the right ventricle/left ventricle (RV/LV) ratio can help radiologists identify patients who have pulmonary hypertension (PH) and would benefit from being referred to a specialist. In a presentation during the 2021 European Congress of Radiology annual meeting, Pia Charters from Royal United Hospital Bath NHS…

Read More

Solving a Genetic Mystery at the Heart of the COVID-19 Pandemic

03/08/2021

Excerpt from the Article: As the COVID-19 pandemic enters its second year, scientists are still working to understand how the SARS-CoV-2 strain evolved, and how it became so much more dangerous than other coronaviruses, which humans have been living alongside for millennia. Virologists and epidemiologists worldwide have speculated for months that a protein called ORF8…

Read More

Immunome Discovers Antibodies Capable of Neutralizing Multiple SARS-CoV-2 Variants, Including the South African Variant, in Pseudovirus Testing

02/26/2021

Excerpt from the Press Release: EXTON, Pa.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced today that its discovery engine has isolated potent antibodies capable of neutralizing several SARS-CoV-2 variants, including the South African Variant (B.1.351), in pseudovirus testing. This…

Read More

Partner Therapeutics Announces Publication of Two Studies Demonstrating Leukine® Improves Survival in Acute Radiation Syndrome (ARS)

02/25/2021

Excerpt from the Press Release: LEXINGTON, Mass., Feb. 18, 2021 /PRNewswire/ — Partner Therapeutics, Inc. (PTx), a commercial biotech company, announces publication of two pivotal studies that provided the basis for approval of Leukine (sargramostim, yeast-derived rhu GM-CSF) to improve survival in patients exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome…

Read More

Immunocore’s tebentafusp granted Breakthrough Therapy Designation for unresectable or metastatic uveal melanoma from FDA

02/24/2021

Excerpt from the Press Release: OXFORDSHIRE, England and CONSHOHOCKEN, Pa. and ROCKVILLE, Md., Feb. 19, 2021 (GLOBE NEWSWIRE) — Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, today…

Read More

MRI Shows Heart Damage in Nearly Half of Patients with Severe COVID-19

02/23/2021

Excerpt from the Article: MRI scans reveal myocarditis, scarring, infarction, and ischemia in recovered patients with elevated troponin levels. Roughly 50 percent of patients who recover after being hospitalized with severe COVID-19 suffer heart damage. MRI scans, conducted at least one month post-discharge, show patients who have elevated levels of troponin show evidence of heart…

Read More

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives